COLDSTREAM CAPITAL MANAGEMENT INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1082339 BELLEVUE, WA

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$675,861

+$103,046 QoQ

Shares Held

8,635

-2.6% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#349

of 664 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 60% Shared 0% None 40%

Healthcare · as of Jun 30, 2026

COLDSTREAM CAPITAL MANAGEMENT INC holds $14,996,603 across 23 Biotechnology names. HALO ranks #6 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,151	$3,055,385
2	TECH	BIO-TECHNE Corp	36,070	$2,548,345
3	JAZZ	Jazz Pharmaceuticals plc	3,849	$927,493
4	REGN	Regeneron Pharmaceuticals, Inc.	1,384	$862,979
5	OMER	Omeros Corp	84,743	$805,905
6	HALO	Halozyme Therapeutics, Inc. This page	8,635	$675,861
7	MRNA	Moderna, Inc.	9,260	$648,477
8	INCY	Incyte Corp	4,536	$514,200

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$675,861	8,635	-2.6%	Shares	Sole	2026-08-14
2026-03-31	$572,815	8,863	-0.1%	Shares	Sole	2026-05-08
2025-12-31	$597,018	8,871	-0.5%	Shares	Sole	2026-02-09
2025-09-30	$653,752	8,914	+1.9%	Shares	Sole	2025-11-19
2025-06-30	$455,122	8,749	-4.6%	Shares	Sole	2025-08-12
2025-03-31	$585,392	9,174	+1.3%	Shares	Sole	2025-05-13
2024-12-31	$432,823	9,053	-2.1%	Shares	Sole	2025-02-14
2024-09-30	$529,527	9,251	+34.7%	Shares	Sole	2024-11-18
2024-06-30	$359,556	6,867	+1.8%	Shares	Sole	2024-08-07
2024-03-31	$274,305	6,743	-2.6%	Shares	Sole	2024-05-14
2023-12-31	$255,800	6,921	+40.4%	Shares	Sole	2024-02-09
2022-12-31	$280,517	4,930	+8.1%	Shares	Sole	2023-01-10
2022-06-30	$200,728	4,562	—	Shares	Sole	2022-08-08
No filing history on record for this holder in this stock.